Büchner, T <br/><br/>
Remission induction therapy: the more intensive the better?  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Aug 2001 
 - S41-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s002800100305  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Age Factors<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Clinical Trials as Topic<br/>Cytarabine--administration & dosage<br/>Daunorubicin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Leukemia, Myeloid--drug therapy<br/>Middle Aged<br/>Remission Induction<br/>Thioguanine--administration & dosage